Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Marie Filhol

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Scientific Reports|January 12, 2016
Design of chimeric antigen receptors with integrated controllable transient functionsAlexandre Juillerat, Alan Marechal, Jean-Marie Filhol, et al.
Scientific Reports|January 21, 2017
An oxygen sensitive self-decision making engineered CAR T-cellAlexandre Juillerat, Alan Marechal, Jean Marie Filhol, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 11, 2015
A Multidrug-resistant Engineered CAR T Cell for Allogeneic Combination ImmunotherapyJulien Valton, Valérie Guyot, Alan Marechal, et al.
Molecular Therapy. Nucleic Acids|December 17, 2017
Fine and Predictable Tuning of TALEN Gene Editing Targeting for Improved T Cell Adoptive ImmunotherapyAnne-Sophie Gautron, Alexandre Juillerat, Valérie Guyot, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Scientific Reports|January 12, 2016
Design of chimeric antigen receptors with integrated controllable transient functionsAlexandre Juillerat, Alan Marechal, Jean-Marie Filhol, et al.
Scientific Reports|January 21, 2017
An oxygen sensitive self-decision making engineered CAR T-cellAlexandre Juillerat, Alan Marechal, Jean Marie Filhol, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 11, 2015
A Multidrug-resistant Engineered CAR T Cell for Allogeneic Combination ImmunotherapyJulien Valton, Valérie Guyot, Alan Marechal, et al.
Molecular Therapy. Nucleic Acids|December 17, 2017
Fine and Predictable Tuning of TALEN Gene Editing Targeting for Improved T Cell Adoptive ImmunotherapyAnne-Sophie Gautron, Alexandre Juillerat, Valérie Guyot, et al.
Pageof 1